Suchergebnisse - "Specchia, Giorgina"

PubPharm (17)

1

JAK2 V617f in chronic myeloid leukemia : driving force or passive bystander?

enthalten in: Hematology (Amsterdam, Netherlands) | 2022

von Tarantini, F. | Cumbo, C. | Zagaria, A. | +11

2

The role of ponatinib in adult BCR-ABL1 positive acute lymphoblastic leukemia after allogeneic transplantation : a real-life retrospective multicenter study

enthalten in: Annals of hematology | 2021

von Leotta, S. | Markovic, U. | Pirosa, M. | +21

3

Next-generation sequencing for BCR-ABL1 kinase domain mutations in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia : A position paper

enthalten in: Cancer medicine | 2020

von Soverini, S. | Albano, F. | Bassan, R. | +11

4

Droplet Digital PCR Is a Robust Tool for Monitoring Minimal Residual Disease in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia

enthalten in: The Journal of molecular diagnostics : JMD | 2018

von Coccaro, N. | Anelli, L. | Zagaria, A. | +12

5

Mutational analysis in BCR-ABL1 positive leukemia by deep sequencing based on nanopore MinION technology

enthalten in: Experimental and molecular pathology | 2017

von Minervini, C. | Cumbo, C. | Orsini, P. | +11

6

BCR-ABL1 e6a2 transcript in chronic myeloid leukemia : biological features and molecular monitoring by droplet digital PCR

enthalten in: Virchows Archiv : an international journal of pathology | 2015

von Zagaria, A. | Anelli, L. | Coccaro, N. | +12

7

The response to imatinib and interferon-alpha is more rapid than the response to imatinib alone : a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase

enthalten in: Haematologica | 2010

von Palandri, F. | Castagnetti, F. | Iacobucci, I. | +17

8

Non random distribution of genomic features in breakpoint regions involved in chronic myeloid leukemia cases with variant t(9;22) or additional chromosomal rearrangements

enthalten in: Molecular cancer | 2010

von Albano, F. | Anelli, L. | Zagaria, A. | +7

9

Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia : a European LeukemiaNet Study

enthalten in: Blood | 2009

von Baccarani, M. | Rosti, G. | Castagnetti, F. | +22

10

Long-term outcome of complete cytogenetic responders after imatinib 400 mg in late chronic phase, philadelphia-positive chronic myeloid leukemia : the GIMEMA Working Party on CML

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2008

von Palandri, F. | Iacobucci, I. | Martinelli, G. | +17